Global Pharmaceutical Fine Chemicals Category - Procurement Market Intelligence Report
Procurement research report on the pharmaceutical fine chemicals market provides procurement professionals with up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services. This report provides a detailed analysis of the supply market, procurement challenges, and procurement best practices, which can help in planning and executing category management activities. It also focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Covered in this report
According to procurement analysts, one of the primary drivers of the pharmaceuticals fine chemicals industry is the increase in drug product approvals in the US by the FDA and in the EU by the EMA. Drug approval is a new opportunity for pharmaceutical fine chemicals manufacturers as pharmaceutical fine chemicals are used as raw materials in the drug formulation process. Furthermore, new drug approvals and patent cliff are leading to the bulk production of several drugs. This, in turn, will be a direct driver for the pharmaceutical fine chemicals industry.
Category driver
One of the procurement best practices for buyers is to adopt measures to enhance visibility over the supply chain. Buyers need to adopt systems and practices that can improve their visibility over the entire supply chain by utilizing digital systems such as QMS, CRM, SCM, and ERP. These digital systems combined with analytical tools can ensure seamless flow of information and provide traceability and visibility across the supply chain.
The use of these systems can help buyers track the following parameters:
Solutions can be categorized into:
Procurement research report on the pharmaceutical fine chemicals market provides procurement professionals with up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services. This report provides a detailed analysis of the supply market, procurement challenges, and procurement best practices, which can help in planning and executing category management activities. It also focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Covered in this report
According to procurement analysts, one of the primary drivers of the pharmaceuticals fine chemicals industry is the increase in drug product approvals in the US by the FDA and in the EU by the EMA. Drug approval is a new opportunity for pharmaceutical fine chemicals manufacturers as pharmaceutical fine chemicals are used as raw materials in the drug formulation process. Furthermore, new drug approvals and patent cliff are leading to the bulk production of several drugs. This, in turn, will be a direct driver for the pharmaceutical fine chemicals industry.
Category driver
One of the procurement best practices for buyers is to adopt measures to enhance visibility over the supply chain. Buyers need to adopt systems and practices that can improve their visibility over the entire supply chain by utilizing digital systems such as QMS, CRM, SCM, and ERP. These digital systems combined with analytical tools can ensure seamless flow of information and provide traceability and visibility across the supply chain.
The use of these systems can help buyers track the following parameters:
- Transaction history
- Chain of custody
- Record of ownership
- Environmental storage conditions
- Manufacturing location
Solutions can be categorized into:
- Basic building blocks
- Advanced intermediates
- Active ingredients
Table of Contents
PART 1: CATEGORY AT A GLANCE- TAKEAWAY 01 - Market Overview
- TAKEAWAY 02 - Demand and Supply Snapshot
- TAKEAWAY 03 - Key Market Dynamics
- TAKEAWAY 04 - Supply Market Highlights
- TAKEAWAY 05 - Pricing Insights
- TAKEAWAY 06 - Procurement Insights
PART 2: SCOPE OF THE REPORT
- Category Definition
- Research Methodology
PART 3: MARKET INSIGHTS
- Category Spend Analysis
- Category Maturity by Regions
- Demand-Supply Shifts
- Regional Demand-Supply Snapshot
- Global Pharmaceutical Fine chemicals Production Hubs
- Market Developments
- Regional Impact of Trends
- Key Category Growth Drivers and Corresponding Regional Impacts
- Major Category Growth Constraints and Corresponding Regional Impacts
- Key Current Technological Innovations
- Major Regulatory Frameworks
- Strategic Sustainability Practices
- Porter’s Five Forces
- PESTLE Analysis
PART 4: SUPPLY MARKET INSIGHTS
- Supplier Operational Capability Matrix
- Other Prominent Suppliers by Region: Operational Capability Matrix
- Supplier Functional Capability Matrix
- Other Prominent Suppliers by Region: Functional Capability Matrix
- Key Clients
- Supplier Cost Breakup
- Supplier Positioning Matrix
PART 5: PRICING INSIGHTS
- Pricing Models Snapshot
- Pricing Models - Pros and Cons
- Indicative Pricing
PART 6: PROCUREMENT INSIGHTS
- Major Category Requirements
- Major Procurement Pain Points
- Category Sourcing Evolution Matrix
- Procurement Best Practices
- Cost-saving Opportunities
- Supplier Selection Criteria
- Category Negotiation Strategies
- SLA Terms
- Supplier Evaluation Criteria
- Category Risk Analysis
PART 7: TOP FIVE SUPPLIERS
- Lonza
- BASF
- Evonik
- DSM
- Boehringer Ingelheim
PART 8: APPENDIX
- Glossary
- Key Notes
- About
Executive Summary
New Report Released: Global Pharmaceutical Fine Chemicals - Procurement Market Intelligence Report 2018-2022.The author of the report recognizes the following companies as the key suppliers in the Global Pharmaceutical Fine Chemicals - Procurement Market Intelligence Report: Lonza, BASF, Evonik, DSM, Boehringer Ingelheim.
Commenting on the report, an analyst from the research team said: “One of the procurement best practices for buyers is to adopt measures to enhance visibility over the supply chain.”
According to the report, one of the key growth contributors for the Global Pharmaceutical Fine Chemicals Market is the growth of the biologics industry.
Further, the report states that major procurement challenge faced by buyers is the difficulty in understanding cost-saving opportunities across supply chains of suppliers.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Companies Mentioned
- Lonza
- BASF
- Evonik
- DSM
- Boehringer Ingelheim
Methodology
LOADING...
